Attending
Memorial Sloan Kettering
New York, New York, United States
Garrett M. Nash, MD, MPH, FACS, FASCRS is the Vice President, Quality and Safety at the Memorial Sloan Kettering Cancer Center. He oversees the Division of Quality and Safety, and his administrative focus is on using data analysis and reporting to drive process improvements, teaching and training, and nurturing a culture of safety and transparency. He prioritizes efforts to increase the reporting of patient safety events across the organization. He is board-certified in surgery and colorectal surgery. His practice includes robotic surgery for colorectal cancer and regional therapy for colorectal and peritoneal cancers including appendix cancer and mesothelioma. He is the primary investigator of ICARuS and ICARuS II (Intraperitoneal Chemotherapy After Cytoreductive Surgery), randomized clinical trials studying the effectiveness of intraperitoneal therapy for colon and appendix cancer and for peritoneal mesothelioma, respectively. He has authored papers on a variety of subjects including cytoreductive surgery, intraperitoneal chemotherapy, minimally invasive surgery, sphincter-sparing rectal surgery, mechanisms of tumor progression, and predictors of outcome following surgery.